Amgros I/S

What Amgros I/S does

Amgros I/S is a Danish pharmaceutical and hearing-aid procurement partnership, founded in 1990 and wholly owned by the five Danish regions (De danske regioner). Operating from Dampfærgevej 22 in Copenhagen, the organization holds an exclusive mandate to conduct centralized EU tenders, negotiate confidential price agreements, and manage supply logistics for all public Danish hospitals. In 2025, Amgros delivered approximately 10.9 billion DKK in procurement savings to its region owners, with services spanning new-medicine price negotiations, generic drug procurement, sustainability-criteria tenders, and strategic pharmaceutical inventory management. Beyond medicines, Amgros runs the national hearing-aid procurement program, including tendering, allocation, and trading through portals such as HA-handel, Samnet, and Høreklinik Offentlig/Pulje, and has expanded into medical equipment procurement in partnership with Regionernes Fællesindkøb.

The company's operating model is that of a publicly commissioned, non-profit procurement agency rather than a commercial enterprise. Revenue is derived from owner-region funding and service commissions rather than product markups; pricing is set via confidential tenders and multi-year agreements with pharmaceutical and hearing-aid suppliers. Amgros's core technology footprint is a set of dedicated portals — Leverandørportalen for suppliers, RHA-databasen for regional health authority data, and the hearing-aid suite — supported by Horizon Scanning pipeline analytics and emergency supply chain tools. Go-to-market is direct B2G: Amgros negotiates and contracts directly with pharmaceutical manufacturers on behalf of hospitals, with no intermediary distribution layer. Leadership is headed by CEO Flemming Sonne, with a staff in the 51-100 range.

In 2025 Amgros is actively broadening its mandate. It signed its first pharmacy-medicine (apoteksmedicin) price agreement under a new pilot, stood up pricing infrastructure for the Danish primary healthcare sector (Primærsektor), and deepened collaboration with the Danish Medicines Council (Medicinrådet) on alternative and outcomes-based price agreements. It has also embedded record levels of sustainability criteria into hospital tenders and is participating in Nordic pharmaceutical cooperation. These moves extend the centralized-negotiation model beyond hospital pharmaceuticals into retail pharmacy, primary care, and medical devices, while tightening its mandate on environmental and outcomes-based procurement.

Name

Amgros I/S

Legal name

Amgros I/S

Website

https://amgros.dk

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

51–100 employees

Short description

Amgros I/S is a Danish regions-owned procurement partnership that runs centralized EU tenders, price negotiations, and supply operations for all public Danish hospitals, delivering approximately 10.9 billion DKK in 2025 savings and now expanding into pharmacy medicine and primary-sector pricing.

Ownership category

akta.pro rank

Product category

Pharmaceutical Procurement Services

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF)

akta.pro secondary industries

Public Health Contracts, Procurement & Vendor Management (HLAJALAE), Tender & Public Procurement Pricing (Hospital/Regional/National Tenders) (HLAIAKAJ), Health Supply Chain, Procurement & Access to Medicines (BPADAIAI), Global Health Supply Chain & Procurement Organizations (HLAJAKAL)

Keywords

• Pharmaceutical procurement
• Medicine supply chain
• Hearing aid procurement
• Public healthcare tenders
• EU tender management

Headquarters

HQ city

Köpenhamn

HQ country

Sweden

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure

Revenue model

1. Pharmaceutical Procurement Services: Amgros operates as a non-profit purchasing organization owned by Danish regions. They negotiate prices and manage EU tenders for pharmaceutical products on behalf of public Danish hospitals. Their value comes from achieving cost savings for their owner regions rather than generating revenue from product sales.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Amgros I/S organizes and conducts pharmaceutical and hearing aid procurement tenders on behalf of the Danish regions, negotiating prices with pharmaceutical companies and suppliers and managing the supply of medicines and hearing aids to public Danish hospitals and hearing clinics. The company achieved savings of approximately 10.9 billion DKK in 2025 through these collective negotiations and manages procurement operations for new medicines, generic drugs, primary sector medications, and medical equipment.

Product overview

Amgros I/S operates as a pharmaceutical procurement and supply organization for Danish public hospitals. The company provides a unified portfolio of services centered on medicine procurement, price negotiations, and supply chain management. Key offerings include the Horizon Scanning service for monitoring pharmaceutical developments, Prisforhandling og Udbud for price negotiations and tenders, and Indkøb og Forsyning for supply chain operations. Additionally, Amgros manages several specialized portals including RHA-databasen (regional health database), Høreklinik Offentlig and Høreklinik Pulje (hearing aid clinic portals), Samnet (hearing aid coordination), HA-handel (hearing aid trading), and Leverandørportalen (supplier portal). The company also handles medical equipment procurement through collaboration with Regionernes Fællesindkøb.

Differentiator

Problem solved

Functional benefit

Products and services

• Horizon Scanning

Quantifiable outcome

• Achieved savings of approximately 10.9 billion DKK in 2025 through pharmaceutical procurement and tender negotiations

Named customers2 records

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Danish Regions (Regionerne)coreStrategic or Co-development PartnerAmgros is owned by Danish regions and serves as their centralized pharmaceutical procurement organization. The regions are both owners and primary beneficiaries of Amgros's negotiation services and cost savings.

Scale indicators2 records

Recent moves2 records

Expansion highlights6 records

Others

• Crown Agents: International development company that runs procurement, supply-chain and capacity-building services for governments and donors. Comparable as a public-sector procurement services provider, though operating commercially and across many product categories rather than Denmark-only.
• Management Sciences for Health (MSH): Global health nonprofit that supports pharmaceutical procurement, supply-chain management and pricing negotiations in low- and middle-income countries. Adjacent comparable in its focus on public-sector pharmaceutical procurement best practice and pricing.

Broad incumbents

• Gavi, the Vaccine Alliance: Multilateral procurement organization that pools vaccine demand across low- and middle-income countries. Comparable to Amgros in using pooled public-sector purchasing power and tenders to drive down pharmaceutical prices, but at global rather than national scale.
• NHS Business Services Authority: Arm's-length body of the UK NHS providing central procurement, reimbursement and supply-chain services. Comparable in function as a large public-sector pharmaceutical purchasing and reimbursement administrator, though operating at national rather than regional level.
• The Global Fund to Fight AIDS, Tuberculosis and Malaria: Multilateral public-sector pooled procurement and grant-making organization for medicines and diagnostics. Comparable in its role as a public-sector aggregator that runs tenders and price negotiations to deliver medicines to public health systems.
• UNICEF Supply Division: UN's central procurement hub for vaccines, medicines and medical supplies, supplying public health systems globally. Functionally comparable to Amgros in the tendering, quality assurance and pooled-volume negotiation of pharmaceuticals and medical devices.

Direct peers

• Legemiddelinnkjøpssamarbeidet (LIS): Norway's national pharmaceutical procurement cooperation, run by the regional health authorities. Directly comparable to Amgros in mandate (centralized hospital drug tendering), ownership structure (public regional health entities), and Nordic public-procurement model.
• TLV (Tandvårds- och läkemedelsförmånsverket): Sweden's Dental and Pharmaceutical Benefits Agency, which negotiates prices and decides on reimbursement for medicines. Closely comparable to Amgros in its public-sector role in pharmaceutical pricing and access decisions in a neighboring Nordic market.
• Regionernes Fællesindkøb (RFI): The Danish regions' joint procurement unit, with which Amgros already collaborates on medical equipment tenders. Directly comparable as a regional public-procurement vehicle in Denmark, focused on non-pharma medical devices and supplies.

Regional players

• Sygehusapotekerne (Hospital Pharmacies of Denmark): The Danish regional hospital pharmacy network that physically receives and dispenses the medicines Amgros tenders for. It is the operational counterpart to Amgros within Denmark and a key stakeholder in the same end-to-end supply chain.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedIndk.linkedin.com/company/amgros-i-s

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Amgros I/S